DrugDashboards
← Home
Manufacturing facility

Aurobindo Pharma Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Unit-III, Sy. No.313 & 314, Bachupally, Bachupally Mandal, Medchal-Malkajgiri District, Medchal, Telangana 500090, India (IND)
Operations here
analysismanufacture
FDA identifiers
FEI 3004021229 · DUNS 918917642

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2023-07-21
  • VAIDrug Quality Assurance2019-07-05
  • VAIDrug Quality Assurance2019-05-24
  • VAIBioresearch Monitoring2018-08-10
  • VAIDrug Quality Assurance2017-04-18
  • NAIDrug Quality Assurance2016-01-29
  • VAIDrug Quality Assurance2015-06-26
  • NAIDrug Quality Assurance2012-03-02
  • NAIBioresearch Monitoring2011-09-08
  • VAIDrug Quality Assurance2011-09-08
  • OAIDrug Quality Assurance2010-09-24
  • NAIDrug Quality Assurance2009-10-22
  • NAIDrug Quality Assurance2009-01-30

Drugs this plant is listed as making

106 distinct drugs across 440 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.